http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2661456-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc57c706887f914f8fff63a63c35584b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f2e80be7e2a714cafc24027b364d22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf95ee2eee45cbf7e8e344426f2a1513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5755b94510e20c3c016119f00a9945d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2beaab654f8dafcb7fc9f856b77bd3a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63d89448b1a0c0b14308c9e9e802e64d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f0e5130ff60441ea689fc1e19d62da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29dc398107d1531764c5049237de2499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86373ad8e98bdbe57932a8db411ca51a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0a3c290014509f6d11f310cf872897 |
| publicationDate | 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2661456-T3 |
| titleOfInvention | Antibacterial tylosin derivatives and methods for their preparation |
| abstract | A compound represented by formula (I): ** Formula * + or a pharmaceutically acceptable salt or solvate thereof; wherein A is selected from halogen, CH2-N3, hydroxy, CHO, CH2-OH, CH2-halogen, and CH2-R '; R1 and R2 taken together are oxo; R3 is hydrogen; R4 is hydrogen; R5 is selected from hydroxy, N3, halogen, 6-deoxy-2,3-di-O-methyl-b-d-allo-hexapyranosyloxy and R '; R7 is selected from hydrogen, C1-C6 alkyl, optionally substituted with one or more substituents selected from the group consisting of halogen, aryl, substituted aryl, heterocyclic and substituted heterocyclic, C2-C6 alkenyl, optionally substituted with one or more selected substituents from the group consisting of halogen, aryl, substituted aryl, heterocyclic, and substituted heterocyclic, C2-C6 alkynyl, optionally substituted with one or more substituents selected from the group consisting of halogen, aryl, substituted aryl, heterocyclic, and substituted heterocyclic; RP is hydrogen; and each R 'is independently 4-R-1,2,3-triazol-1-yl; and wherein each R is independently selected from the group consisting of: (1) C1-C9 alkyl, optionally substituted with one or more substituents selected from the group consisting of halogen, aryl, substituted aryl, heterocyclic, and substituted heterocyclic, -OR7 where R7 is as previously defined; (2) C2-C9 alkenyl, optionally substituted with one or more substituents selected from the group consisting of halogen, aryl, substituted aryl, heterocyclic, and substituted heterocyclic, -OR7 where R7 is as defined above; (3) C2-C9 alkynyl, optionally substituted with one or more substituents selected from the group consisting of halogen, aryl, substituted aryl, heterocyclic and substituted heterocyclic, -OR7 where R7 is as defined above; (4) C3-C14 cycloalkyl; (5) C3-C14 substituted cycloalkyl; (6) aryl; (7) substituted aryl; (8) heterocyclic; (9) substituted heterocyclic; and (10) -COOR7, where R7 is as defined above; with the proviso that at least one of A and R5 is defined as A> = CH2-R 'and / or R5> = R'. |
| priorityDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.